Reuters logo
BRIEF-Index Pharmaceuticals gets patent for additional DIMS compounds granted in US
March 14, 2017 / 7:11 AM / 8 months ago

BRIEF-Index Pharmaceuticals gets patent for additional DIMS compounds granted in US

March 14 (Reuters) - Index Pharmaceuticals Holding AB:

* Says patent covering 19 compounds from company’s DIMS platform has been granted by United States Patent and Trademark Office (USPTO) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below